A股收評:滬指四連陽!IPV6、華為昇騰、鴻蒙等板塊活躍
A股主要指數今日升跌不一,截至收盤,滬指升0.44%報2748點,深證成指升0.1%,創業板指跌0.4%。上升與下跌個股數相當,全天成交5510億元,較前一交易日縮量237億元。盤面上,IPV6板塊走高,電科網安、大唐電信升停;華為昇騰、鴻蒙板塊活躍,常山北明等多股升停;美《生物安全法》未被納入美國《2025財年國防授權法案》,CRO板塊走高,睿智醫藥20%升停;國企改革概念股拉昇,湖南天雁等多股升停;銀行、煤炭及北斗導航等板塊升幅居前。另外,光伏設備板塊下挫,德業股份跌停;百元股普跌,禾邁股份等多股跌超5%;風電設備板塊走弱,大金重工領跌;BC電池、多元金融及注射器概念等跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.